Brand Names: Rituxan,
Rituxan (rituximab) is a cancer drug which works to disrupt the growth, transport, and survival of cancer cells in the body. Rituximab is prescribed for use against non-Hodgkin’s lymphoma or chronic lymphocytic leukemia. Rituxan can be used to treat other severe complications related to inflammatory conditions, including rheumatoid arthritis and inflammation of blood vessels or other tissues.
It is important that you understand that Rituximab has many serious potential side effects, and it is important that you fully understand the risks involved.
While Rituximab can be very expensive when purchased in-stores, you can buy rituximab online for a fraction of the cost. Save up to 90% when you order your prescription rituximab online.
Rituximab sold as Rituxan comes in a 500mg/50mL vial.
Taken from RxList
FATAL INFUSION REACTIONS, SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Rituxan administration can result in serious, including fatal infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions [see WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS].
Severe Mucocutaneous Reactions
Hepatitis B Virus (HBV) Reactivation
HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis , hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation [see WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS].